Your browser doesn't support javascript.
loading
Finalising the administration of co-SSPedi, a dyad approach to symptom screening for paediatric patients receiving cancer treatments.
Tomlinson, Deborah; Schechter, Tal; Mairs, Mark; Loves, Robyn; Herman, Daniel; Hopkins, Emily; Dupuis, L Lee; Sung, Lillian.
Afiliação
  • Tomlinson D; Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada deborah.tomlinson@sickkids.ca.
  • Schechter T; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Mairs M; Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Loves R; Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Herman D; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Hopkins E; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Dupuis LL; Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Sung L; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
BMJ Support Palliat Care ; 13(e2): e469-e475, 2023 Dec 07.
Article em En | MEDLINE | ID: mdl-34556545
ABSTRACT

OBJECTIVES:

Symptom Screening in Pediatrics Tool (SSPedi) is a validated self-report symptom screening tool for patients with cancer 8-18 years of age. Co-SSPedi is a novel dyad approach in which both child and parent complete SSPedi together. The objective was to finalise the approach to co-SSPedi administration with instruction that is easy to understand, resulting in dyads completing co-SSPedi correctly.

METHOD:

We enrolled child and parent dyads, who understood English and where children (4-18 years) had cancer or were hematopoietic stem cell transplantation recipients. We provided each dyad with instruction on how to complete co-SSPedi together. Mixed methods were used to determine how easy or hard the instruction was to understand. Two raters adjudicated if co-SSPedi was completed correctly. Dyads were enrolled in cohorts of 12 evenly divided by age (4-7, 8-10, 11-14 and 15-18 years).

RESULTS:

We enrolled 5 cohorts of 12 dyads, resulting in 60 dyads. Following verbal instruction provided in the first cohort, we identified the need for written instruction emphasising children should wait for parent response prior to entering scores. The instruction was iteratively refined based on qualitative feedback until the fifth cohort, where all 12 dyads found the instruction easy to understand and completed co-SSPedi correctly.

CONCLUSIONS:

We developed a standard approach to dyad symptom screening named co-SSPedi with instruction that is easy to understand, resulting in correct co-SSPedi completion. Future efforts should focus on co-SSPedi validation and understanding how co-SSPedi scores compare to self- or proxy-reported symptom reporting.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Detecção Precoce de Câncer / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Detecção Precoce de Câncer / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies Limite: Child / Child, preschool / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article